DAVID POPLACK to Sarcoma
This is a "connection" page, showing publications DAVID POPLACK has written about Sarcoma.
Connection Strength
0.055
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.027
-
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
Score: 0.021
-
A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Invest New Drugs. 1996; 13(4):337-42.
Score: 0.007